We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+2.8%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$498M
AUM Growth
+$156M
Cap. Flow
+$153M
Cap. Flow %
30.77%
Top 10 Hldgs %
9.37%
Holding
695
New
367
Increased
87
Reduced
105
Closed
136

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$4.9M
2
CMCSA icon
Comcast
CMCSA
+$4.8M
3
SPGI icon
S&P Global
SPGI
+$4.68M
4
DLTR icon
Dollar Tree
DLTR
+$4.47M
5
EXC icon
Exelon
EXC
+$4.36M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$3.61M
2
CTSH icon
Cognizant
CTSH
+$3.56M
3
NKE icon
Nike
NKE
+$3.54M
4
QCOM icon
Qualcomm
QCOM
+$3.4M
5
ACN icon
Accenture
ACN
+$3.4M

Sector Composition

Rank Sector Weight
1 Financials 15.57%
2 Technology 15.37%
3 Consumer Discretionary 12.98%
4 Industrials 11.46%
5 Healthcare 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TT icon
351
Trane Technologies
TT
$98.8B
$306K 0.06%
4,084
+100
+3% +$7.21K
CNQ icon
352
Canadian Natural Resources
CNQ
$96.9B
$303K 0.06%
+19,411
New +$308K
JKHY icon
353
Jack Henry & Associates
JKHY
$11.4B
$302K 0.06%
+3,400
New +$290K
ROK icon
354
Rockwell Automation
ROK
$51.1B
$302K 0.06%
+2,250
New +$287K
TTM
355
DELISTED
Tata Motors Limited
TTM
$298K 0.06%
8,653
+200
+2% +$7.38K
DCH
356
Dauch Corp
DCH
$1.31B
$297K 0.06%
+15,400
New +$261K
VTLE
357
DELISTED
Vital Energy
VTLE
$296K 0.06%
+1,048
New +$288K
BWLD
358
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$295K 0.06%
+1,913
New +$297K
ZTS icon
359
Zoetis
ZTS
$32.7B
$293K 0.06%
+5,479
New +$279K
ING icon
360
ING
ING
$92.9B
$292K 0.06%
+20,700
New +$279K
HLF icon
361
Herbalife
HLF
$1.3B
$290K 0.06%
+12,050
New +$329K
WST icon
362
West Pharmaceutical
WST
$23.7B
$288K 0.06%
3,400
-12,400
-78% -$975K
CAVM
363
DELISTED
Cavium, Inc.
CAVM
$287K 0.06%
+4,600
New +$266K
MNDT
364
DELISTED
Mandiant, Inc. Common Stock
MNDT
$286K 0.06%
+23,993
New +$311K
IVZ icon
365
Invesco
IVZ
$12.4B
$285K 0.06%
+9,387
New +$289K
KLAC icon
366
KLA
KLAC
$222B
$278K 0.06%
35,360
-155,280
-81% -$1.19M
WFT
367
DELISTED
Weatherford International plc
WFT
$277K 0.06%
55,500
-11,011
-17% -$57.6K
BIO icon
368
Bio-Rad Laboratories Class A
BIO
$8.76B
$273K 0.05%
+1,500
New +$256K
HCA icon
369
HCA Healthcare
HCA
$90.6B
$273K 0.05%
3,683
-6,662
-64% -$499K
EFX icon
370
Equifax
EFX
$22B
$272K 0.05%
+2,300
New +$281K
ECL icon
371
Ecolab
ECL
$79.8B
$270K 0.05%
+2,300
New +$269K
HRL icon
372
Hormel Foods
HRL
$14.2B
$270K 0.05%
+7,766
New +$280K
MKC icon
373
McCormick & Company Non-Voting
MKC
$14B
$268K 0.05%
+5,736
New +$268K
COL
374
DELISTED
Rockwell Collins
COL
$268K 0.05%
+2,889
New +$255K
RYAAY icon
375
Ryanair
RYAAY
$30B
$266K 0.05%
7,993
+250
+3% +$7.87K

Similar funds

Seven Eight Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Seven Eight Capital held 695 positions worth $498M, up 45% from $342M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Seven Eight Capital deployed $153M of net new capital in Q4 2016, opening 367 new positions and adding to 87 existing holdings. Its largest new stake was Texas Instruments: 68,700 shares worth $5.01M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 9.5% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was RTX Corp, an estimated $3.61M trimmed.

  • Seven Eight Capital's largest Q4 2016 buy was Texas Instruments: 68,700 shares worth $5.01M.
  • Seven Eight Capital added most to S&P Global in Q4 2016, an estimated $4.68M increase.
  • Seven Eight Capital's biggest Q4 2016 reduction was RTX Corp, cutting an estimated $3.61M.
  • Seven Eight Capital fully exited Cognizant in Q4 2016, selling an estimated $3.56M.
  • Seven Eight Capital's ten largest holdings make up 9.4% of its $498M portfolio in Q4 2016.
  • Seven Eight Capital opened 367 new positions and closed 136 in Q4 2016.
  • Seven Eight Capital's portfolio value rose 45% quarter-over-quarter to $498M.

Based on Seven Eight Capital's 13F filing for Q4 2016, filed 14 Feb 2017.